IRIS
PENNISI, MARIA STELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.213
EU - Europa 539
AS - Asia 469
SA - Sud America 180
AF - Africa 160
OC - Oceania 1
Totale 2.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.195
IT - Italia 253
SG - Singapore 214
BR - Brasile 165
CN - Cina 122
CI - Costa d'Avorio 113
IE - Irlanda 95
DE - Germania 52
IN - India 43
SN - Senegal 35
VN - Vietnam 31
RU - Federazione Russa 26
FI - Finlandia 22
GB - Regno Unito 20
CA - Canada 13
BE - Belgio 12
CZ - Repubblica Ceca 8
JP - Giappone 8
SE - Svezia 8
KR - Corea 7
PL - Polonia 7
TR - Turchia 7
UZ - Uzbekistan 7
AR - Argentina 6
HK - Hong Kong 6
UA - Ucraina 6
FR - Francia 5
IQ - Iraq 5
CH - Svizzera 4
ES - Italia 4
MX - Messico 4
NO - Norvegia 4
AE - Emirati Arabi Uniti 3
BD - Bangladesh 3
EC - Ecuador 3
ID - Indonesia 3
IL - Israele 3
MA - Marocco 3
ZA - Sudafrica 3
CO - Colombia 2
GR - Grecia 2
HU - Ungheria 2
KE - Kenya 2
NG - Nigeria 2
NL - Olanda 2
PE - Perù 2
TN - Tunisia 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
UY - Uruguay 1
Totale 2.562
Salva come PNG Salva come JPEG
Città #
Santa Clara 213
Dallas 212
Chandler 194
Singapore 145
Abidjan 113
Chicago 101
Dublin 95
Catania 62
Ashburn 41
Civitanova Marche 34
Dakar 34
Beijing 33
Kochi 32
Boardman 31
Cambridge 27
Lawrence 25
Los Angeles 25
Andover 24
Grafing 23
Dong Ket 22
Wilmington 17
Munich 16
The Dalles 15
Des Moines 14
Columbus 13
Brussels 12
Council Bluffs 12
New York 12
Turku 12
Hefei 11
Palermo 11
São Paulo 11
Nanjing 10
Belo Horizonte 9
Hanoi 9
Santa Venerina 9
Brno 8
Helsinki 8
Tokyo 8
Bari 7
Seoul 7
Milan 6
Pune 6
Aci Catena 5
Rio de Janeiro 5
Seattle 5
Toronto 5
Bremen 4
Edinburgh 4
Falls Church 4
Frankfurt am Main 4
Giardini-Naxos 4
Hong Kong 4
Houston 4
Jiaxing 4
Montreal 4
Saint Petersburg 4
Tremestieri Etneo 4
Catanzaro 3
Fantina 3
Guarulhos 3
Hanover 3
Jakarta 3
Jinan 3
Johannesburg 3
London 3
Manaus 3
Manchester 3
Messina 3
Oslo 3
San Giovanni la Punta 3
Tashkent 3
Volta Redonda 3
Warsaw 3
Woodbridge 3
Abuja 2
Baghdad 2
Belém 2
Blumenau 2
Boston 2
Brasília 2
Cabo Frio 2
Campo Grande 2
Casablanca 2
Chennai 2
Comiso 2
Cáceres 2
Dubai 2
Duque de Caxias 2
Fairfield 2
Istanbul 2
Jacksonville 2
Joinville 2
La Plata 2
Lappeenranta 2
Madrid 2
Marília 2
Mascali 2
Mexico City 2
Moscow 2
Totale 1.894
Salva come PNG Salva come JPEG
Nome #
Clinical Implications of Discordant Early Molecular Responses in CML Patients Treated with Imatinib 174
Non ABL-directed inhibitors as alternative treatment strategies for chronic myeloid leukemia 127
Activation of the IGF axis in thyroid cancer: Implications for tumorigenesis and treatment 121
A novel system for semiautomatic sample processing in chronic myeloid leukaemia: Increasing throughput without impacting on molecular monitoring at time of sars-cov-2 pandemic 118
Additional Genetic Alterations and Clonal Evolution of MPNs with Double Mutations on the MPL Gene: Two Case Reports 107
BCR-ABL1 doubling-times and halving-times may predict CML response to tyrosine kinase inhibitors 107
Molecular Alterations in Thyroid Cancer: From Bench to Clinical Practice 103
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 103
Colony-forming cell assay detecting the co-expression of JAK2 V617F and BCR-ABL1 in the same clone: A case report 100
B-ALL relapses after autologous stem cell transplantation associated with a shift from e1a2 to e14a2 BCR-ABL transcripts: A case report 100
Efficacy of Dasatinib in a Very Elderly CML Patient Expressing a Rare E13a3 Bcr-Abl1 Fusion Transcript: A Case Report 99
ABL1-Directed Inhibitors for CML: Efficacy, Resistance and Future Perspectives 99
New insights in thyroid cancer and p53 family proteins 95
Efficacy of Nilotinib in a CML Patient Expressing the Three-way Complex Variant Translocation t(2;9;22) 94
Impact of Different Cell Counting Methods in Molecular Monitoring of Chronic Myeloid Leukemia Patients. 93
Impact of the Breakpoint Region on the Leukemogenic Potential and the TKI Responsiveness of Atypical BCR-ABL1 Transcripts 91
Optimal Response in a Patient With CML Expressing BCR-ABL1 E6A2 Fusion Transcript With Nilotinib Therapy: A Case Report 85
Combined inhibition of bcl2 and bcr-abl1 exercises anti-leukemia activity but does not eradicate the primitive leukemic cells 85
Successful management of a pregnant patient with chronic myeloid leukemia receiving standard dose imatinib 84
Opportunities and challenges of liquid biopsy in thyroid cancer 83
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma 80
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 80
Rapid decline of philadelphia-positive metaphases after nilotinib treatment in a CML patient expressing a rare e14a3 BCR-ABL1 fusion transcript: A case report 70
Targeting BCL-2 as a therapeutic strategy for primary p210BCR-ABL1-positive B-ALL cells 70
Molecular pathogenesis and treatment perspectives for hypereosinophilia and hypereosinophilic syndromes 70
High BCR::ABL1 Expression Defines CD34+ Cells with Significant Alterations in Signal Transduction, Short-Proliferative Potential and Self-Renewal Ability 69
The Role of New Technologies in Myeloproliferative Neoplasms 64
Multiple primary malignances managed with surgical excision: a case report with next generation sequencing analysis 62
Totale 2.633
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.479
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.479
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 10 23 5 2 2 26 2 3 27
2021/2022184 1 33 6 3 37 4 30 6 7 1 12 44
2022/2023515 29 46 23 68 28 75 3 108 98 5 23 9
2023/2024299 21 49 11 9 10 76 2 19 2 11 68 21
2024/2025959 13 154 38 87 187 132 97 30 31 46 113 31
2025/2026433 97 94 230 12 0 0 0 0 0 0 0 0
Totale 2.633